There was an inverse correlation between the BCR/ABL protein levels, indicated by immunohistochemistry staining, and miR-320a expression assessed by in situ hybridization in 90 CML cancer stem cells on TMAs as used above (Fig. 4G). The gene discussed is BCR; the disease is cancer.